CDSCO UID MFG/IVD/2022/000045_d540a3cd5516c790dadac9865611f8ce_a3be2decf83b39e88319c025a7ae2c39
Dengue NS1 Rapid
Promea Therapeutics Private Limited·Device Class Class C·India CDSCO
Registration details
- UID
- MFG/IVD/2022/000045_d540a3cd5516c790dadac9865611f8ce_a3be2decf83b39e88319c025a7ae2c39
- Device class
- Class C
- License holder
- Promea Therapeutics Private Limited
- Approving authority
- CDSCO, Zonal office, Hyderabad
- Product information
- Dengue NS1 Rapid is an immunochromatographic assay for the qualitative detection of non- structural protein 1 ##PLACEHOLDER_0## antigen in serum/plasma
Other products from Promea Therapeutics Private Limited
Products from the same license holder (10 products)
TRIPLEX HBV/HCV/HIV RT-PCR
Class D
Inactivation Transport Medium
Class C
Nucleic Acid Extraction Kit
Brand: ProPCR
Class C
COVID 19 RT-qPCR
Brand: ProPCR
Class C
Blood Glucose Meter Smart - GDH
Brand: P. falciparum, histidine-rich protein II
Class C
HBsAg Rapid Kit
Brand: IgG and IgM
Class D
Blood Glucose Meter- GDH
Brand: P. falciparum, histidine-rich protein II
Class C
Blood Glucose Meter- GOD
Brand: P. falciparum, histidine-rich protein II
Class C
Blood Glucose Meter Smart - GOD
Brand: P. falciparum, histidine-rich protein II
Class C
HCV Rapid
Class D
About this record
Dengue NS1 Rapid is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2022/000045_d540a3cd5516c790dadac9865611f8ce_a3be2decf83b39e88319c025a7ae2c39. The license holder is Promea Therapeutics Private Limited, and it is classified as Device Class Class C. The approving authority is CDSCO, Zonal office, Hyderabad.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.